NCT04157569招募中不适用
Monitoring Circulating Tumor DNA After Chemotherapy in Elderly Patients With Acute Leukemia
Navy General Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年11月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- cumulative incidence of relapse(CIR)
研究概览
简要总结
This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL
详细描述
This study will use droplet digital PCR (ddPCR) method to quantify peripheral blood plasma mutant allele frequency (MAF) in elderly acute leukemia patients after chemotherapy to evaluate the clinical value of CtDNA .
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 60 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent
- •not pregnant female
- •patients >=60 years old
- •Diagnosis of acute leukemia
排除标准
- •Pregnancy
- •HIV positive
- •patients >=100 years old
结局指标
主要结局
cumulative incidence of relapse(CIR)
时间窗: through study completion, an average of 1 year
cumulative incidence of relapse
次要结局
- overall survival (OS)(through study completion, an average of 2 years)
研究者
Liren Qian
Principal Investigator
Navy General Hospital, Beijing
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract CarcinomaBiliary Tract CancerNCT06171321Shanghai East Hospital94
招募中
不适用
ctDNA Monitoring in Early Breast CancerBreast CancerNCT04353557Geneplus-Beijing Co. Ltd.200
终止
2 期
Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast CancerHER2-negative Metastatic Breast CancerNCT04720729Institut Curie160
Unknown
不适用
Circulating Tumor DNA in Surgical Lung Cancer PatientsLung NeoplasmsNCT03081741Shenzhen Gene Health Bio Tech Co., Ltd.500
招募中
3 期
CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: a Single-center, Randomized, Controlled StudyColon Cancer (stage II & III)Colon CancerNCT06609551Zhejiang Cancer Hospital312